Doubts about cholesterol drugs Zetia and Vytorin
A small study is stirring up big questions about ezetimibe, the active ingredient in the popular cholesterol medicines Zetia and Vytorin.
A small study is stirring up big questions about ezetimibe, the active ingredient in the popular cholesterol medicines Zetia and Vytorin.
Experts say it is clear that the drugs lower so-called bad cholesterol. But a new study suggests that a common form of vitamin B works better to reduce artery plaque and prevent heart attack and stroke. Drug maker Merck & Co. called the study “flawed.”
Find more coverage from National Public Radio:
Doubts Grow About Zetia, Vytorin In Wake Of Niacin Test
Merck’s Vytorin, Zetia Cholesterol Drugs Questioned
WHYY is your source for fact-based, in-depth journalism and information. As a nonprofit organization, we rely on financial support from readers like you. Please give today.